Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brimonidine Implant in Geographic Atrophy
NCT02087085Phase 2Terminated
- Sponsor
- Allergan
- Start
- May 2014
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of brimonidine in geographic atrophy (GA), sponsored by Allergan. Started May 2014; status: terminated.
02
Drugs
brimonidine
03
Conditions
geographic atrophy (GA)
Beyond the preview
Go deeper on NCT02087085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02087085.